Navigation Links
FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
Date:3/21/2011

ose limited because of adverse side effects, such as gastrointestinal intolerance, liver enzyme elevations and flushing. The Company believes that ARI-3037MO can produce greater therapeutic benefits than existing forms of niacin as a result of mitigating such adverse side effects.  

In preclinical studies involving hamsters fed a high-fat diet, ARI-3037MO showed robust changes in lipids, including LDL and HDL cholesterols and triglycerides (TGs).  Specifically, once-daily treatments of ARI-3037MO lowered both LDL cholesterol and TGs greater than 70% from placebo.  In comparison, higher doses of niacin reduced LDL cholesterol and TGs approximately 50% from placebo.  Additionally, ARI-3037MO increased the proportion of HDL cholesterol to a greater extent than niacin.  ARI-3037MO treated hamsters showed a significant increase in ATP-binding cassette transporter A1 (ABCA1), apolipoprotein A-1 (ApoA1), and adiponectin compared to the vehicle control animals.  The ABCA1 and ApoAI increases are noteworthy, as the proteins that result from these transcripts are involved in the synthesis and maturation of HDL.  

"Significant lipid changes coupled with the increased mRNA levels for certain regulatory proteins involved in HDL synthesis and reverse cholesterol transport offers compelling evidence to support the mechanism based efficacy of this niacin analog," commented, Dr. Ernst Schaefer, Professor of Medicine, Tufts University School of Medicine. "The availability of an effective and tolerable niacin replacement would be a major advancement for the treatment of mixed lipid disorders."

In addition to the compelling preclinical efficacy, ARI-3037MO did not induce "flushing" as measured by changes in capillary blood flow via the ear in mice. Such capillary blood flow measurements have translated well in evaluating the effects of niacin on flushing in human clinical trials. Additionally, flushing was not observed during clin
'/>"/>

SOURCE Arisaph Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
2. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
3. The SCOOTER Store Accepts Medicare Contracts
4. FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review
5. FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
6. FDA Accepts Sanofi Pasteurs Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
7. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
8. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
9. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
10. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
11. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... CASTLE ROCK, Colo. , Aug. 28, 2014 /PRNewswire/ ... diagnostic company focused on obtaining FDA clearance for ... a rapid blood test for aiding in identifying children, ... who are at low risk for appendicitis, today announced ... Rodman & Renshaw 16 th Annual Global Investment ...
(Date:8/28/2014)... DIEGO , Aug. 28, 2014 Telik, ... development company that merged with MabVax Therapeutics, Inc. ... made significant progress related to the development of ... antibody was recovered using the Company,s internally developed ... the potential for multiple antibody based therapeutic and ...
(Date:8/28/2014)... DUBLIN, Ohio , Aug. 28, 2014 /PRNewswire/ ... rising competition in generics are adding pressure to ... internal resources. Company resources continue to shrink and ... complex. This has led companies to look for ... to commercialization and for keeping approved products on ...
Breaking Medicine Technology:Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 44 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4
(Date:8/28/2014)... Involution Studios , a software ... industry's most pressing problems, has launched three open ... Involution Studios' creative team has been on the ... clients including AstraZeneca, 3M Health Information Systems, Partners ... studio's philosophy to change healthcare in a positive ...
(Date:8/28/2014)... 28, 2014 Starting on Monday, the ... able to accept donations in Bitcoin, in addition to ... page can be found at http://www.curemeso.org/bitcoin . ... as a form of payment, we decided it was ... Foundation’s chief executive officer, Melinda Kotzian. , Bitcoin ...
(Date:8/28/2014)... (PRWEB) August 29, 2014 Recently, Skmen.com, ... women’s clothes, has revealed its unique collection of ... promotion. At the moment, all the company’s newly unveiled ... 29 percent off. , As a matter of ... its business growth in the recent years. The company’s ...
(Date:8/28/2014)... The Global and China Oscilloscope Industry is ... of the Oscilloscope industry in Global and China. , ... including definitions, applications and industry chain structure. Global market ... a focus on history, developments, trends and competitive landscape ... Chinese situation is also offered. , The report also ...
(Date:8/28/2014)... HORNE LLP has laid out the challenge to ... million firm has more than feel-good emotions at stake, ... balance. , Described by experts in the accounting industry ... Boomers creating succession issues, poor leadership development strategies, new ... wars within firms that are threatening the life of ...
Breaking Medicine News(10 mins):Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Skmen.com: Bestselling Long Sleeve Sweater Dresses Are Offered Online Now 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2
... HealthDay Reporter , TUESDAY, July 19 (HealthDay News) -- ... cancer are undergoing chemotherapy may help prevent early menopause and ... July 20 issue of the Journal of the American ... hormone triptorelin when a patient is undergoing chemotherapy helped prevent ...
... , TUESDAY, July 19 (HealthDay News) -- The antidepressants ... provide no appreciable relief, and may raise the ... "The two classes of antidepressants most likely ... no more effective than placebo," the study authors said. ...
... July, 2011 The Research4Life partners today announced two ... case study competition on how HINARI, AGORA, and/or OARE ... a pediatrician from Nepal and Mr. Mulugeta Bayisa, a ... over 60 entries to the competition held in celebration ...
... Radiation Oncology (ASTRO) has named its 2011 class of ... designation at a ceremony during the Society,s 53rd Annual ... Beach Convention Center in Miami Beach, Fla. , "ASTRO ... members of the radiation oncology community and receiving this ...
... a part of its new initiative, Expanding Access to Opioid ... Europe and Central Asia (EECA), the International AIDS Society (IAS) ... in partnership with the Ukrainian Institute on Public Health Policy ... 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS ...
... HILL, N.C. Women who have breastfeeding difficulties in ... likely to suffer postpartum depression two months later compared ... women with breastfeeding difficulties should be screened for depressive ... the University of North Carolina at Chapel Hill. ...
Cached Medicine News:Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 2Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 3Health News:Two Antidepressants Given to Dementia Patients Ineffective: Study 2Health News:Joint winners announced in Research4life global case study competition 2Health News:Joint winners announced in Research4life global case study competition 3Health News:ASTRO announces 2011 Fellows class 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 3Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 4Health News:Mothers with breastfeeding difficulties more likely to suffer postpartum depression 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: